AMP-activated protein kinase agonist dose dependently improves function and reduces apoptsis in gluctoxic β-cels without changing triglyceride levels

Journal of Molecular Endocrinology

Volumn 41, Issue 3-4, 2008, Pages 187-194

  Nyblom, Hanna K ^a   Sargsyan, Ernest ^a   Bergsten, Peter ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; ACETYL COENZYME A CARBOXYLASE; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL CELL CULTURE; APOPTOSIS; ARTICLE; CELL COUNT; CELL ENERGY; CELL SECRETION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOTOXICITY; DRUG MECHANISM; ENERGY YIELD; ENZYME PHOSPHORYLATION; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULINOMA; LIPID ANALYSIS; NONHUMAN; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT;

AMINOIMIDAZOLE CARBOXAMIDE; AMP-ACTIVATED PROTEIN KINASES; APOPTOSIS; BIOLOGICAL MARKERS; CARBON-CARBON LIGASES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOPLASMIC RETICULUM; GLUCOSE; INSULIN; INSULIN-SECRETING CELLS; PHOSPHORYLATION; RIBONUCLEOTIDES; TRANSCRIPTION FACTOR CHOP; TRIGLYCERIDES;

EID: 55749090598     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/JME-08-0006     Document Type: Article

References (49)

1. Akkan AG & Malaisse WJ 1994 Insulinotropic action of AICA riboside. I. Insulin release by isolated islets and the perfused pancreas. Diabetes Research 25 13-23.
2. Bergsten P & Hellman B 1993 Glucose-induced amplitude regulation of pulsatile insulin secretion from individual pancreatic islets. Diabetes 42 670-674.
3. Berne C 1975 The metabolism of lipids in mouse pancreatic islets. The biosynthesis of triacylglycerols and phospholipids. Biochemical Journal 152 667-673.
4. Briaud I, Harmon JS, Kelpe CL, Segu VB & Poitout V 2001 Lipotoxicity of the pancreatic β-cell is associated with glucose-dependent esterification of fatty acids into neutral lipids. Diabetes 50 315-321.
5. Busch AK, Gurisik E, Cordery DV, Sudlow M, Denver GS, Laybutt DR, Hughes WE & Biden TJ 2005 Increased fatty acid desaturation and enhanced expression of stearoyl coenzyme A desaturase protects pancreatic β-cells from lipoapoptosis. Diabetes 54 2917-2924.
6. Butler AF, Janson J, Bonner-Weir S, Ritzel R, Rizza RA & Butler PC 2003 β-cell deficit and increased β-cell apoptosis in humans with type 2 diabetes. Diabetes 52 102-110.
7. Cai Y, Martens GA, Hinke SA, Heimberg H, Pipeleers D & Van de Casteele M 2007 Increased oxygen radical formation and mitochondrial dysfunction mediate β cell apoptosis under conditions of AMP-activaLed protein kinase stimulation. Free Radical Biology and Medicine 42 64-78.
8. Cnop M, Hannaert JC, Hoorens A, Eizirik DL & Pipeleers DG 2001 Inverse relationship between cytotoxicity of free fatty acids in pancreatic islet cells and cellular triglyceride accumulation. Diabetes 50 1771-1777.
9. Corton JM, Gillespie JG, Hawley SA & Hardie DG 1995 5-Aminoimidazole -4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? European Journal of Biochemistry 229 558-565.
10. Diraison F, Motakis E, Parton LE, Nason GP, Leclerc I & Rutter GA 2004 Impact of adenoviral transduction with SREBP1c or AMPK on pancreatic islet gene expression profile: analysis with oligonucleotide microarrays. Diabetes 53 S84-S91.
11. Dunlop ME & Larkins RG 1985 Pancreatic islets synthesize phospholipids de novo from glucose via acyl-dihydroxyacetone phosphate. Biochemical and Biophysical Research Communications 132 467-473.
12. Eizirik DL, Korbutt GS & Hellerstrom C 1992 Prolonged exposure of human pancreatic islets to high glucose concentrations in vitro impairs the γ-cell function. Journal of Clinical Investigation 90 1263-1268.
13. El-Assaad W, Buteau J, Peyot ML, Nolan C, Roduit R, Hardy S, Joly E, Dbaibo G, Rosenberg L & Prentki M 2003 Saturated fatty acids synergize with elevated glucose to cause pancreatic β-cell death. Endocrinology 144 4154-4163.
14. El-Mir MY, Nogueira V, Fontaine E, Averet N, Rigoulet M & Leverve X 2000 Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I. Journal of Biological Chemistry 275 223-228.
15. Harding HP & Ron D 2002 Endoplasmic reticulum, stress and the development of diabetes: a review. Diabetes 51 S455-S461.
16. Higa M, Zhou YT, Ravazzola M, Baetens D, Orci L & Unger RH 1999 Troglitazone prevents mitochondrial alterations, β cell destruction, and diabetes in obese prediabetic rats. PNAS 96 11513-11518.
17. Kahn BB, Alquier T, Carling D & Hardie DG 2005 AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metabolism 1 15-25.
18. Kim WH, Lee JW, Suh YH, Lee HJ, Lee SH, Oh YK, Gao B & Jung MH 2007 AICAR potentiates ROS production induced by chronic high glucose: roles of AMPK in pancreatic β-cell apoptosis. Cellular Signalling 19 791-805.
19. Laybutt DR, Preston AM, Akerfeldt MC, Kench JG, Busch AK, Biankin AV & Biden TJ 2007 Endoplasmic reticulum stress contributes to β cell apoptosis in type 2 diabetes. Diabetologia 50 752-763.
20. Leclerc I, Woltersdorf WW, da Silva Xavier G, Rowe RL, Cross SE, Korbutt GS, Rajotte RV, Smith R & Rutter GA 2004 Metformin, but not leptin, regulates AMP-activated protein kinase in pancreatic islets: impact on glucose-stimulated insulin secretion. American Journal of Physiology. Endocrinology and Metabolism 286 E1023-E1031.
21. Leonardi O, Mints G & Hussain MA 2003 β-cell apoptosis in the pathogenesis of human type 2 diabetes mellitus. European Journal of Endocrinology 149 99-102.
22. Lupi R, Del Guerra S, Fierabracci V, Marselli L, Novelli M, Patane G, Boggi U, Mosca F, Piro S, Del Prato S et al. 2002a Lipotoxicity in human pancreatic islets and the protective effect of metformin. Diabetes 51 S134-S137.
23. Lupi R, Dotta F, Marselli L, Del Guerra S, Masini M, Santangelo C, Patane G, Boggi U, Piro S, Anello M et al. 2002b Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that β-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated. Diabetes 51 1437-1442.
24. Malaisse WJ, Conget I, Sener A & Rorsman P 1994 Insulinotropic action of AICA riboside. II. Secretory, metabolic and cationic aspects. Diabetes Research 25 25-37.
25. Marchetti P, Del Guerra S, Marselli L, Lupi R, Masini M, Pollera M, Bugliani M, Boggi U, Vistoli F, Mosca F et al. 2004 Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin. Journal of Clinical Endocrinology and Metabolism 89 5535-5541.
26. Merrill GF, Kurth EJ, Hardie DG & Winder WW 1997 AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. American Journal of Physiology 273 E1107-E1112.
27. Milburn JL Jr, Hirose H, Lee YH, Nagasawa Y, Ogawa A, Ohneda M, BeltrandelRio H, Newgard CB, Johnson JH & Unger RH 1995 Pancreatic β-cells in obesity. Evidence for induction of functional, morphologic, and metabolic abnormalities by increased long chain fatty acids. Journal of Biological Chemistry 270 1295-1299.
28. Moffitt JH, Fielding BA, Evershed R, Berstan R, Currie JM & Clark A 2005 Adverse physicochemical properties of tripalmitin in β cells lead to morphological changes and lipotoxicity in vitro. Diabetologia 48 1819-1829.
29. Muoio DM, Seefeld K, Witters LA & Coleman RA 1999 AMP-activated kinase reciprocally regulates triacylglycerol synthesis and fatty acid oxidation in liver and muscle: evidence that sn-glycerol-3-phosphate acyltransferase is a novel target. Biochemical Journal 338 783-791.
30. Nyblom HK, Thorn K, Ahmed M & Bergsten P 2006 Mitochondrial protein patterns correlating with impaired insulin secretion from INS-1E cells exposed to elevated glucose concentrations. Proteomics 6 5193-5198.
31. Nyblom HK, Nord LI, Andersson R, Kenne L & Bergsten P 2008 Glucose-induced de novo synthesis of fatty acyls causes proportional increases in INS-1E cellular lipids. NMR in Biomedicine 21 357-365.
32. Roche E, Farfari S, Witters LA, Assimacopoulos-Jeannet F, Thumelin S, Brun T, Corkey BE, Saba AK & Prentki M 1998 Long-term exposure of β-INS cells to high glucose concentrations increases anaplerosis, lipogenesis, and lipogenic gene expression. Diabetes 47 1086-1094.
33. Rutkowski DT & Kaufman RJ 2004 A trip to the ER: coping with stress. Trends in Cell Biology 14 20-28.
34. Rutter GA, Da Silva Xavier G & Leclerc I 2003 Roles of 5′-AMP-activated protein kinase (AMPK) in mammalian glucose homoeostasis. Biochemical Journal 375 1-16.
35. Salt IP, Johnson G, Ashcroft SJ & Hardie DG 1998 AMP-activated protein kinase is activated by low glucose in cell lines derived from pancreatic β cells, and may regulate insulin release. Biochemical Journal 335 533-539.
36. Shimabukuro M, Zhou YT, Levi M & Unger RH 1998 Fatty acid-induced β cell apoptosis: a link between obesity and diabetes. PNAS 95 2498-2502.
37. da Silva Xavier G, Leclerc I, Varadi A, Tsuboi T, Moule SK & Rutter GA 2003 Role for AMP-activated protein kinase in glucose-stimulated insulin secretion and preproinsulin gene expression. Biochemical Journal 371 761-774.
38. Unger RH, Zhou YT & Orci L 1999 Regulation of fatty acid homeostasis in cells: novel role of leptin. PNAS 96 2327-2332.
39. Velasco G, Geelen MJ & Guzman M 1997 Control of hepatic fatty acid oxidation by 5′-AMP-activated protein kinase involves a malonyl-CoA -dependent and a malonyl-CoA-independent mechanism. Archives of Biochemistry and Biophysics 337 169-175.
40. Wang H, Maechler P, Antinozzi PA, Herrero L, Hagenfeldt-Johansson KA, Bjorklund A & Wollheim CB 2003 The transcription factor SREBP-1c is instrumental in the development of β-cell dysfunction. Journal of Biological Chemistry 278 16622-16629.
41. Wang H, Kourri G & Wollheim CB 2005a ER stress and SREBP-1 activation are implicated in β-cell glucolipotoxicity. Journal of Cell Science 118 3905-3915.
42. ATP channel-dependent and -independent pathways. Biochemical and Biophysical Research Communications 330 1073-1079.
43. Winder WW 2001 Energy-sensing and signaling by AMP-activated protein kinase in skeletal muscle. Journal of Applied Physiology 91 1017-1028.
44. Winder WW & Hardie DG 1999 AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes. American Journal of Physiology 277 E1-E10.
45. Yamashita T, Eto K, Okazaki Y, Yamashita S, Yamauchi T, Sekine N, Nagai R, Noda M & Kadowaki T 2004 Role of uncoupling protein-2 up-regulation and triglyceride accumulation in impaired glucose-stimulated insulin secretion in a β-cell lipotoxicity model over-expressing sterol regulatory element-binding protein-1c. Endocrinology 145 3566-3577.
46. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K et al. 2002 Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nature Medicine 8 1288-1295.
47. Zhang S & Kim KH 1995 Glucose activation of acetyl-CoA carboxylase in association with insulin secretion in a pancreatic β-cell line. Journal of Endocrinology 147 33-41.
48. Zhou YP & Grill VE 1994 Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. Journal of Clinical Investigation 93 870-876.
49. Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N et al. 2001 Role of AMP-activated protein kinase in mechanism of metformin action. Journal of Clinical Investigation 108 1167-1174.